Anti-antibiotic: the resistance
move
|
||
India faces a serious health crisis of rising antibiotic
resistance thanks to doctors prescribing them unscrupulously.
|
||
Pooja Malhotra can’t remember the number of times she has been
prescribed antibiotics for a simple cold and cough. The 23-year-old says that
many of her friends and family have, like her, blindly popped antibiotics for
years without knowing that they are not required to treat coughs and colds.
Prescribing antibiotics has become common place among medicine practitioners
in India, and is a leading factor contributing to rising antibiotic
resistance in the country, say health experts.
According to the World Health Organisation (WHO), antibiotic
resistance causes people to become sick for longer periods and increases the
risk of death. For example, people with MRSA (methicillin-resistant
staphylococcus aureus) bacteria are 64 per cent more likely to die than
people with a non-resistant form of the infection.
Recent data studies have revealed a six-fold increase in the
number of antibiotics being popped by Indians. Effective and inexpensive
antibiotics like ciprofoxcillin, septran, ampicillin, amoxicillin,
roxythromycin and chloramphenicol are now useless in most cases as bacteria
have developed resistance to these, says Dr Shrirang Bichu, a nephrologist at
Bombay Hospital. “In fact, many higher antibiotics like cefuroxime,
ceftriaxone, pipracillin and cefoperazone are also becoming ineffective in
most cases. If left uncontrolled, a time will soon come when we will be left
with no effective antibiotics.”
Passing the bug
Dr Camilla Rodrigues, consultant microbiologist and chairperson
of the Infection Control Committee at PD Hinduja Hospital, revealed that
antibiotic resistance in India is rising because of the absence of good
sanitation in community and hospitals. “Every stakeholder needs to act
responsibly if we have to control antibiotic resistance. Whether it is a
farmer or someone dealing with livestock or a doctor — everyone is using
antibiotics without thinking about the consequences,” she says, adding that a
person developing antibiotic resistance has widespread implications for
society as s/he can spread the resistant bug to others.
Treating gram negative infections — which mostly affect
hospitalised patients — is becoming difficult because the category of
bacteria is evolving and becoming ever more immune to existing antibiotics,
adds Dr Bichu. Bacteria classified as gram-negative because of their reaction
to the so-called gram stain test can cause severe pneumonia and infections of
the urinary tract, bloodstream and other parts of the body. Their cell
structure makes them resistant to attack with antibiotics than gram-positive
organisms like MRSA. “Gram negative infections are a matter of immense
concern. This not only leads to prolonged hospital stay but also leads to
increased treatment cost,” says Dr Om Shrivastava, infectious disease expert
at Jaslok Hospital.
According to Dr Khusrav Bajan, an intensivist at Hinduja,
“Community acquired pneumonia, urinary tract infections and typhoid are the
three diseases whose treatment is most affected because of incidences of
antibiotic resistance.”
Stronger dose, longer recovery
Dr Indraneel Raut, chief intensivist at Jaslok Hospital, gave
the example of a 48-year-old male patient who had been admitted to the
hospital and was receiving immunosuppressive drugs because of a kidney
transplant earlier. “He was admitted for pneumonia infection with a
multi-drug resistant bacteria. He was treated with a higher-than-usual dose
of antibiotics that finally cleared the infection from his lungs. We've been
increasingly seeing more cases of antibiotic resistance,” says Raut.
The hospital's microbiology department confirmed that resistance
of klebsiella to carbapenem and third generation cephalosporins plus
betalactamase inhibitor combination drugs has increased by approximately 20
per cent in 2015 as compared to in 2012.
“Resistance to aminoglycosides has increased by 22 per cent.
However, resistance of gram positive bacteria, such as staphylococcus aureus,
towards the antibiotics has not increased significantly. This data is derived
from patients coming from the community, transferred from other hospitals and
immunocompromised patients,” says Dr Sonar Narula, consultant microbiologist
at Jaslok.
The Ministry of Health and Family Welfare has now included
high-end antibiotics into Schedule H1 drug category wherein the chemist has
to maintain a separate register to keep record of name and address of the
prescriber, name of the patient, drug name, quantity, etc. In order to
strengthen the surveillance of antimicrobial resistance (AMR) in the country,
the Indian Council of Medical Research has set up a National Anti-Microbial
Resistance Research and Surveillance Network to enable compilation of
national data of AMR.
santosh.andhale@dnaindia.net,
somita.pal@dnaindia.net, @dna
|
Monday, January 25, 2016
HEALTH SPECIAL ................Anti-antibiotic: the resistance move
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment